Why invest in
Aqua Bio Technology?
ABT develops new active ingredients for skincare. Invest in the sustainable future of skincare
Top 20 investors
Management and board
Chairman of the Board
Edvard Cock (b. 1969) has served as Chairman of the Board since 2016. He is a lawyer and partner with the law firm CLP, having worked as a business attorney since 1997. Mr Cock holds an MBA degree from the University of Michigan and a cand. jur. law degree from the University of Oslo.
Tone Bjørnov (b. 1961) has served on the board since 2008. She is a full-time board member serving on the boards of several public and private companies. Her background is in bank and finance, including having served as an executive with DNB Bank. Ms Bjørnov holds a business degree from the Norwegian School of Management (BI).
Kristin Aase (b. 1961) has served on the board since 2015. She is an adviser and partner with the consulting firm Novera. She has held leadership positions within several organisations and enterprises. Ms Aase holds a cand. polit. degree from the University of Oslo.
Jan Pettersson (b. 1957) has served on the board since 2015. He is a private investor who takes an active ownership role within several sectors, including the fish industry. Mr Petterson has studied law at the University of Stockholm.
Roger Hofseth (b. 1974) has served on the board since 2019. He is a private investor who takes an active ownership role within several marine companies/sectors, including the fish industry, with more than 20 years of experience.
Håvard Lindstrøm (b. 1969) has served as ABT’s CEO since 7th of July 2021. Before that he held the position as Head of Business Development since August 2020. Mr Lindstrøm has more than 24 years experience from sales and distribution, and holds a Master in marketing management degree from BI/NMH Norwegian Business School.
Espen Kvale (b. 1976) has a background in dermatology and immunology from international companies within pharmaceuticals, cosmetics and consumer products. Mr Kvale holds a masters degree from The School of Pharmacy, University of Oslo and a PhD in Immunology.
Aqua Bio Technology ASA is listed on the Oslo Stock Exchange’s Axess market (ticker: ABT). The ABT shares are distributed among approximately 2990 shareholders.
Analyst, Norne securities
+47 21 95 37 49